ASH 2021 Final Results of a Phase 2 Study of Sotatercept for Anemia of MPN-Associated Myelofibrosis

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASH 2021 Final Results of a Phase 2 Study of Sotatercept for Anemia of MPN-Associated Myelofibrosis

By ASH 2021 Conference Coverage on VuMedi FEATURING Prithviraj Bose

98 views

December 20, 2021

Comments 0

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal

An ITP Case Study of Treating a Patient Who Was Non-responsive to St…

Feat. J. Bussel

Diagnosing Iron Deficiency: Redefining Standards and Dispelling Myths

Michael Auerbach

4.9K views

2 months ago

Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

1.4K views

4 weeks ago

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Indy Hematology Review

A. Tefferi

1.4K views

6 months ago

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

1.3K views

6 months ago

ASH 2023 Insights: "IV Iron Formulations - History, Safety and Admin…

Insights from 2023 ASH Annual Meeting

M. Auerbach

1.2K views

10 months ago

Anemia: Beyond Iron Deficiency!

Scripps Health

A. Goodman

3.0K views

1 year ago

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

415 views

1 month ago

Identifying and Treating Iron Deficiency in Pregnancy

Steven Fein

501 views

6 months ago

Anemia Case Discussion: Anemia Secondary to Malabsorption Syndromes

APP2APP Virtual Lectures, Inc

D. Thomas

153 views

4 months ago

Momelotinib for Myelofibrosis: Top 10 Things You Should Know Post-FD…

Ruben Mesa

932 views

1 year ago

Review of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

2.7K views

1 year ago

16:51

Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Iron Supplementation for Iron Deficiency Anemia

Evidence-Based Hair

J. Donovan

1.6K views

1 year ago

SIMPLIFY-2 Trial: Momelotinib Vs. Continued Ruxolitinib or Best Avai…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

302 views

4 months ago

16:26

Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Current and Future Treatment Landscape of Myelofibrosis

XV Eurasian Hematology-Oncology Congress - EHOC 2024

R. Komrokji

138 views

1 month ago

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Indy Hematology Review

R. Rampal

326 views

7 months ago

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

156 views

4 weeks ago

Anemia and Thrombocytopenia Basics

UNC Lineberger Comprehensive Cancer Center

N. Vogler

280 views

4 months ago

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implicat…

Insights from 2023 ASH Annual Meeting

D. Tremblay

402 views

9 months ago

AUTOPLAY

Login

Login

Join VuMedi

ASH 2021 Final Results of a Phase 2 Study of Sotatercept for Anemia of MPN-Associated Myelofibrosis

Importance of Early Management of Patients with Myelofibrosis (MF)

An ITP Case Study of Treating a Patient Who Was Non-responsive to St…

Recommended

Diagnosing Iron Deficiency: Redefining Standards and Dispelling Myths

Intravenous Iron for Heart Failure: Where Is the Evidence?

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Current Approaches in the Treatment of Myeloproliferative Neoplasms

ASH 2023 Insights: "IV Iron Formulations - History, Safety and Admin…

Anemia: Beyond Iron Deficiency!

ESMO 2024 Summary: Highlights in Heme Malignancies

Identifying and Treating Iron Deficiency in Pregnancy

Anemia Case Discussion: Anemia Secondary to Malabsorption Syndromes

Momelotinib for Myelofibrosis: Top 10 Things You Should Know Post-FD…

Review of Myeloproliferative Neoplasms

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Iron Supplementation for Iron Deficiency Anemia

SIMPLIFY-2 Trial: Momelotinib Vs. Continued Ruxolitinib or Best Avai…

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Current and Future Treatment Landscape of Myelofibrosis

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Myeloid Malignancies: Hot Topics in 2024

Anemia and Thrombocytopenia Basics

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implicat…